Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Quantum-Si ( (QSI) ) has provided an update.
On December 29, 2025, Quantum-Si posted an updated corporate presentation for investors on its website, outlining its strategy to capitalize on what it sees as a more than $75 billion and rapidly growing proteomics market. The materials highlight the company’s differentiated single-molecule protein sequencing technology, the growing user base and published data for its first-to-market Platinum Pro system, and plans to use Platinum Pro to build commercial infrastructure ahead of the planned Proteus platform launch, which is designed to deliver automated, high-value proteoform and post-translational modification analysis more broadly across laboratories. The presentation underscores Quantum-Si’s existing global distribution network, partnerships across commercialization, product development and manufacturing, a cash runway extending into the second quarter of 2028, and its view that scalable, affordable protein sequencing will be critical to meeting rising demand for complex, high-resolution proteomics across research and emerging clinical applications.
The most recent analyst rating on (QSI) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Quantum-Si stock, see the QSI Stock Forecast page.
Spark’s Take on QSI Stock
According to Spark, TipRanks’ AI Analyst, QSI is a Neutral.
Quantum-Si’s overall stock score reflects significant financial challenges, particularly in profitability and cash flow management. Technical analysis indicates potential bearish momentum, and valuation metrics are unattractive due to ongoing losses. However, the company’s focus on innovation and strategic product developments, as highlighted in the earnings call and corporate events, provide some optimism for future growth.
To see Spark’s full report on QSI stock, click here.
More about Quantum-Si
Quantum-Si is a life sciences tools company focused on proteomics, developing single-molecule protein sequencing platforms and related instruments, kits and software for deep protein and proteoform analysis. Its offerings, including the commercialized Platinum Pro system and the in-development Proteus platform, target a broad range of end markets such as academic research, pharma and biotech, industrial, defense, clinical diagnostics, translational research and agriculture, with a strategy built around patented technology, global distribution partnerships and a large, expanding proteomics market opportunity.
Average Trading Volume: 9,848,551
Technical Sentiment Signal: Sell
Current Market Cap: $265.1M
Find detailed analytics on QSI stock on TipRanks’ Stock Analysis page.